Phage therapy could be key to conquering persistent bacterial lung infections in children

Aye Mya Sithu Shein1,2, Parichart Hongsing3,4, Aisha Khatib5

  • 1Department of Microbiology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.

PubMed

Insights

Phage therapy shows promise for treating persistent bacterial lung infections in children, offering a potential alternative to antibiotics. Further research and collaboration are key to its advancement.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pediatrics

Background:

  • Persistent bacterial lung infections in children contribute to significant illness and death.
  • Antibiotic resistance poses a major challenge in treating these infections.

Purpose of the Study:

  • To review the efficacy of phage therapy in treating pediatric bacterial lung infections.
  • To highlight phage therapy as a potential alternative to conventional antibiotics.

Main Methods:

  • Review of preclinical and clinical studies on phage therapy.
  • Analysis of various administration routes and their effectiveness.
  • Examination of ongoing clinical trials.

Main Results:

  • Phage therapy has demonstrated significant therapeutic benefits in preclinical and clinical settings.
  • Various administration routes have been effective in delivering phage therapy.
  • Ongoing trials are assessing the safety and efficacy against diverse pathogens.

Conclusions:

  • Phage therapy presents a viable alternative to antibiotics for persistent bacterial lung infections in children.
  • Systematic studies and international collaboration are crucial for advancing phage therapy.

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.2K
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
61.8K
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
1.0K
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
395
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
296
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170